Both in Pharmaceuticals
Olema Pharmaceuticals vs ArriVent BioPharma
Over the past year OLMA returned −12.2% and AVBP returned −26.9%; their daily moves had a correlation of 0.08.
OLMA −12.2% AVBP −26.9%Growth of $1, one year, split-adjusted
| Metric | OLMA | AVBP |
|---|---|---|
| Price | $7.40 | $12.87 |
| Market cap | $647.0M | $634.6M |
| Today | +0.61% | −1.15% |
| 1 month | −6.6% | −14.7% |
| 6 months | −51.3% | −56.5% |
| Year to date | −70.4% | −36.0% |
| 1 year | −12.2% | −26.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $458.1M | $373.1M |
| Dividend yield | — | — |
| Volatility (60d) | 54.7% | 154.3% |
| Short % of float | 24.8% | 20.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).